Owner Bill Casner hasn't wavered since his 2011 decision to race his Thoroughbreds without the widely used diuretic furosemide, or Salix (Lasix).
Mubtaahij has never raced on the anti-bleeding medication Lasix, and he will run without it in the Kentucky Derby, becoming the first horse in 10 years to do so.
Trainer Michael Dickinson explains why he has joined the ranks of WHOA members working to pass federal legislation to prohibit the use of performance-enhancing drugs in North American horse racing.
The Kentucky Horse Racing Commission March 23 approved a regulation that would permit the state's racetracks to card races that would prohibit the administration of furosemide within 24 hours of post time.
New York regulators March 23 said they want to hold a forum to consider the future use of anti-bleeding medication furosemide in the state.
The Kentucky Horse Racing Commission is considering a proposal that would permit the state's racetracks to card races that would prohibit the administration of furosemide within 24 hours of post time.
Kentucky Equine Research president Joe Pagan, Ph.D., will discuss proper nutrition for horses being treated with Lasix (furosemide, formally called Salix) at a March 16 seminar in Ocala, Fla.
Legislation governing equine medication policy is scheduled to be heard Feb. 18 by the Florida Senate Regulated Industries Committee.
The RMTC said Dec. 9 the Thoroughbred industry has made "major gains" this year in the number of jurisdictions operating or soon to be operating under all or part of the National Uniform Medication Program.
Gulfstream Park will begin third-party administration of race-day furosemide beginning Wednesday, Nov. 19.
Ogden Phipps said Oct. 6 a centralized regulatory body for horse racing would facilitate changes necessary to improve the integrity of the sport in the United States, but the chances of it happening are slim to none.
Charles J. Cella, president of Oaklawn Racing & Gaming, announced Sept. 18 that the Arkansas track in 2015 will offer purse bonuses for horses that run and win without furosemide (Salix or commonly called Lasix).
Jockey Club says a recent study's findings challenge long-held opinions in North American racing, including the contention that the use of the diuretic furosemide is necessary to ensure long-term careers of horses.
A study published online this spring found no link between the vast majority of horses who suffer from exercise-induced pulmonary hemorrhage and long-term racing performance.
A Kentucky racing official Sept. 12 said the state has been at the forefront of research into cobalt, a naturally occurring element said to have blood-doping qualities if used at high levels.
Kentucky regulators are considering allowing tracks in the state to card races that would prohibit the administration of race-day furosemide, commonly called Salix or Lasix.
The National Horsemen's Benevolent and Protective Association restated its strong support for the continued use of Lasix (furosemide, also commonly called Salix) at its summer convention Aug.15-17 in Oklahoma City.
In response to a statement from 25 prominent horsemen calling for a ban on the race-day use of furosemide, the Florida Horsemen's Benevolent and Protective Association Aug. 8 issued an open letter opposing changes.
In response to several top trainers calling for the end of race-day furosemide, horsemen's groups throughout the country say they will continue to support the use of the diuretic to prevent or reduce the severity of EIPH.
Eliminating race-day Salix is gaining momentum. read blog
Some of North America's top trainers are backing a plan to eliminate the use of race-day medication in the U.S. beginning next season with 2-year-olds, and expanding to all horses in 2016.
A new study finds no difference in the racing career longevity between horses who experience some level of exercise-induced pulmonary hemorrhage and those who never experience EIPH.
Multiple racing jurisdictions have adopted all or parts of the National Uniform Medication Program, with others expected to be on board by the end of this year.
Images from a race day with a Kentucky state veterinarian at Keeneland. A companion to the article in the June 28/July 5 edition of The Blood-Horse. View Slideshow
The Jockey Club should push for more in-depth furosemide research. read blog
The Jockey Club has called on leading industry organizations to come together to conduct a Salix study that would examine the timing of administration on the medication used to prevent exercise-induced pulmonary hemorrhage.
Dr. Christopher Riggs, head of veterinary clinic services for The Hong Kong Jockey Club, provides insight into how medication is dispensed and monitored at the HKJC racetracks.
At least one regulator investigating violations alleged in a PETA video posted last month involving the stable of trainer Steve Asmussen expects the inquiry to take at least several months.
People for the Ethical Treatment of Animals said it will "go away" if horse racing addresses its medication issues, and industry officials who have been trying to do just that suggest progress is evident but not recognized.
Kentucky horsemen March 14 were given an overview of impending equine medication changes and also provided with a few tips to avoid headaches when the new regulations take effect later in the spring.
A Jan. 30 meeting of racing stakeholders in the Mid-Atlantic and Northeast regions showed how difficult it can be to achieve uniformity, even with the best intentions or most basic of regulations.
Here's a follow-up look at racing statistics of juveniles involved in the furosemide observational study results released Dec. 16 by Breeders' Cup from this year's World Championships and two California-bred stakes.
Study finds 2-year-olds racing without race-day furosemide at 2013 Breeders' Cup World Championships at Santa Anita Park had fewer and less severe EIPH instances than juveniles who raced with the diuretic that weekend at SA.
Breeders' Cup chairman Bill Farish acknowledged the organization's board of directors has some key issues it needs to address, not the least of which is the host-site selection process.
More owners and trainers are finding Salix-free success. read blog
The Maryland Racing Commission Sept. 17 adopted uniform medication and drug-testing rules as part of a push in the Mid-Atlantic region.
Though Breeders' Cup this year will "monitor the performance" of 2-year-olds that must race without furosemide in its World Championships, the therapeutic medication will be available for use in all races for the 2014 event.
Horses competing in the upcoming Breeders' Cup at Santa Anita Park will form a test sample of the potential effects of running without anti-bleeding medications, but it will be up to their owners whether to participate.
An initial introduction in Kentucky of the Mid-Atlantic Uniform Medication Program received raised eyebrows, but supporters of the changes are encouraged that the important racing state is giving the program consideration.
For the second year in a row, many of horse racing's top owners have pledged to race their juvenile starters without race-day medication.
The West Virginia Racing Commission July 23 unanimously approved revised Thoroughbred racing rules, including several amendments that deal with equine medication and drug testing.
Regulatory administration of race-day anti-bleeding medication in Kentucky has provided a clearer picture of drug testing and produced added security benefits, officials said.
A study conducted at Kentucky Equine Research indicates that 72 hours after being administered Salix (furosemide, also commonly called Lasix), active horses had difficulty replenishing calcium levels.
Saying he saw an opposition to openness and transparency among some members that degenerated to personal attacks, longtime member Satish Sanan resigned from his Breeders' Cup board position May 9.
A half-dozen horses entered in this year's Kentucky Derby Presented by Yum! Brands (gr. I) field made their initial starts without race-day Salix, but for the 1 1/4-mile classic all six will receive the diuretic.
Treatment of exercise-induced pulmonary hemorrhage by non-medicinal means was discussed April 9 during a seminar that focused on use of FLAIR Nasal Strips.
Among the speakers for an April 9 seminar on exercise-induced pulmonary hemorrhage are three trainers, officials announced.
- By Tom LaMarra
The horse racing industry is taking a closer look at a relaxant that produces optimum results when administered within a few hours of a race. The prevalence of GABA, a supplement, is open to speculation.
With Breeders' Cup at least slowing implementation of its race-day Salix prohibition, the Kentucky Horse Racing Commission could revisit its plans to ban use of the diuretic on race day.
The regulators of eight states in the Northeast region have committed to a uniform medication and drug testing program in a move supporters believe is a step toward uniform regulation of medication and drug testing.
Most Popular Stories
- Favored American Pharoah Wins Kentucky Derby
- Preakness Could Be Rematch for Derby Top 3
- Longtime Owner/Breeder Miles Dies at 85
- Kentucky Derby Wrap
- Able Friend Wins Champions Mile in Easy Romp
- Derby Overnight Rating Highest Since 1992
- Gold Ship Sails to Breakthrough Tenno Sho Win
- Kentucky Derby: Carrots for American Pharoah
- 2015 Kentucky Derby Race Sequence
- Baffert: Derby Win 'Was a Big Sigh of Relief'